Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature

被引：0
|
作者：
Huanhuan Xu
Qi Liang
Xian Xu
Shanyue Tan
Sumeng Wang
Yiqian Liu
Lingxiang Liu
机构：
[1] The First Affiliated Hospital of Nanjing Medical University,Department of Oncology
来源：
World Journal of Surgical Oncology | / 19卷
关键词：
Afatinib; Anlotinib; HER2 mutation; Lung adenocarcinoma; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature
    Xu, Huanhuan
    Liang, Qi
    Xu, Xian
    Tan, Shanyue
    Wang, Sumeng
    Liu, Yiqian
    Liu, Lingxiang
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [2] Afatinib as first-line treatment for advanced lung adenocarcinoma patients harboring HER2 mutation: A case report and review of the literature
    Shi, Yuequan
    Wang, Mengzhao
    [J]. THORACIC CANCER, 2018, 9 (12) : 1788 - 1794
  • [3] Advanced lung adenocarcinoma with coexistent HER2 mutation and amplification and response to afatinib: a case report
    Liu, Xiaona
    Cao, Yuqing
    Li, Yuxin
    Duan, Xiumei
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (02) : 483 - 487
  • [4] Pyrotinib in the treatment of advanced lung adenocarcinoma with HER2 exon 20 mutation: a case report and literature review
    Luo, Ying
    Yao, Bin
    Huang, Ping
    Zhao, Yiting
    Chen, Jun
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (12) : 12906 - 12910
  • [5] The effect of afatinib in a pretreated patient with invasive mucinous adenocarcinoma of the lung harboring HER2 YVMA insertion: a case report
    He, Yueming
    Huang, Hong
    Xu, Meng
    Fu, Zhihui
    Zhang, Xiang'e
    Chen, Xiaoyan
    Guo, Weifeng
    [J]. TRANSLATIONAL CANCER RESEARCH, 2022, 11 (06) : 1819 - 1823
  • [6] Combined therapy with osimertinib and afatinib in a lung adenocarcinoma patient with EGFR T790M mutation and multiple HER2 alterations after resistance to icotinib: A case report
    Zhang, Ping
    Nie, Xin
    Wang, Bing
    Li, Lin
    [J]. THORACIC CANCER, 2018, 9 (12) : 1774 - 1777
  • [7] Efficacy generated by afatinib in a lung adenocarcinoma patient harboring HER2 S310Y mutation
    Wang, Jian
    Wen, Yuxin
    Ding, Guanggui
    Ding, Peikun
    Zhang, Lu
    Liu, Jing
    Zhang, Tengfei
    Yang, Lin
    [J]. CANCER BIOLOGY & THERAPY, 2018, 19 (06) : 450 - 453
  • [8] Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient- a case report
    Zhou, Li
    Ren, Yifeng
    Wang, Xia
    Miao, Dongliu
    Lizaso, Analyn
    Li, Haiyan
    Han Han-Zhang
    Qian, Jun
    Yang, Hui
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 5305 - 5309
  • [9] Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib A case report
    Cai, Yangyang
    Wang, Xu
    Guo, Ye
    Sun, Chao
    Xu, Yinghui
    Qiu, Shi
    Ma, Kewei
    [J]. MEDICINE, 2019, 98 (01)
  • [10] Efficacy of Afatinib in a PreviouslyTreated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report
    Park, Cheol Kyu
    Hur, Jae Young
    Choi, Chang-Min
    Kim, Tae-Ok
    Cho, Hyun-Ju
    Shin, Hong-Joon
    Lim, Jung-Hwan
    Choi, Yoo-Duk
    Kim, Young-Chul
    Oh, In-Jae
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (01)
12345